Lung Cancer pp 131-142 | Cite as

The development and progression of adenocarcinoma of the lung

  • Masayuki Noguchi
  • Yukío Shimosato
Part of the Cancer Treatment and Research book series (CTAR, volume 72)


Adenocarcinoma is the most common lung cancer in Japan and is said to be increasing in some other countries. Etiologically, it is less strongly associated with cigarette smoking than either squamous cell carcinoma or small cell carcinoma, and the mechanism of carcinogenesis of adenocarcinoma is not well understood.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Shimosato Y, Kodama T, Kameya T. 1982. Morphogenesis of peripheral type adenocarcinoma of the lung. In Morphogenesis of Lung Cancer, Y Shimosato, MR Melamed, and P Nettesheim (eds.). CRC Press: Boca Raton, FL, pp. 65–89.Google Scholar
  2. 2.
    Clayton F. 1988. The spectrum and significance of bronchioloalveolar carcinomas. Pathol Annu 23(part 2):361–394.PubMedGoogle Scholar
  3. 3.
    Nomori H, Matsuno Y, Noguchi M, Tsugane S, Shimosato Y, Hirohashi S. 1992. Adenocarcinoma of the lung with selective metastasis to the lung: Clinical, histologic and DNA-cytofluorometric analyses. Jpn J Cancer Res 83:93–100.PubMedCrossRefGoogle Scholar
  4. 4.
    Gemma A, Noguchi M, Hirohashi S, Tsugane S, Tsuchiya R, Niitani H, Shimosato Y. 1991. Clinicopathologic and immunohistochemical characteristics of goblet cell type adenocarcinoma of the lung. Acta Pathol Jpn 41:737–743.PubMedGoogle Scholar
  5. 5.
    Hirata H, Noguchi M, Shimosato Y, Uei Y, Goya T. 1990. Clinicopathological and immunohistochemical characteristics of bronchial gland cell type adenocarcinoma of the lung. Am J Clin Pathol 93:20–25.PubMedGoogle Scholar
  6. 6.
    Shimosato Y, Hashimoto T, Kodama T, et al. 1979. Prognostic implications of fibrotic focus (scar) in small peripheral lung cancer. Am J Surg Pathol 4:365–373.CrossRefGoogle Scholar
  7. 7.
    Suzuki A. 1982. Growth characterictics of peripheral type adenocarcinoma of the lung in terms of roentgenologic findings. In Morphogenesis of Lung Cancer, Y Shimosato, MR Melamed, and P Nettesheim (eds.). CRC Press: Boca Raton, FL, pp. 91–110.Google Scholar
  8. 8.
    Miller RR. 1990. Bronchioloalveolar cell adenomas. Am J Surg Pathol 14:904–912.PubMedCrossRefGoogle Scholar
  9. 9.
    Miller RR, Nelems B, Evans KG, Müller NL, Ostrow DN. 1988. Glandular neoplasia of the lung. A proposed analogy to colonic tumors. Cancer 61:1009–1014.PubMedCrossRefGoogle Scholar
  10. 10.
    Kodama T, Biyajima S, Watanabe S, Shimosato Y. 1986. Morphometric study of adeno-carcinomas and hyperplastic epithelial lesions in the peripheral lung. Am J Clin Pathol 85:146–151.PubMedGoogle Scholar
  11. 11.
    Nakayama H, Noguchi M, Tsuchiya R, Kodama T, Shimosato Y. 1990. Clonal growth of atypical adenomatous hyperplasia of the lung: cytofluorometric analysis of nuclear DNA content. Modern Pathol 3:314–320.Google Scholar
  12. 12.
    Shimosato Y. 1989. Pulmonary neoplasms. In Diagnostic Surgical Pathology, vol. 1, SS Sternberg (ed.). Raven Press: New York, pp. 758–827.Google Scholar
  13. 13.
    Shimosato Y, Noguchi M, Matsuno Y. 1993. Adenocarcinoma of the lung: its development and malignant progression. Lung Cancer 9:99–108.CrossRefGoogle Scholar
  14. 14.
    Kurakawa T, Matsuno Y, Noguchi M, Mizuno S, Shimosato Y. 1995. Surgically curable “early” adenocarcinoma in the periphery of the lung. Am J Surg Pathol 18(5):431–438.CrossRefGoogle Scholar
  15. 15.
    Takamori S, Noguchi M, Morinaga S, Goya T, Tsugane S, Kakegawa T, Shimosato Y. 1991. Clinicopathologic characteristics of adenosquamous carcinoma of the lung. Cancer 67:649–654.PubMedCrossRefGoogle Scholar
  16. 16.
    Yoshida K, Morinaga S, Shimosato Y, Hayata Y. 1989. A cell kinetic study of pulmonary adenocarcinoma by an immunoperoxidase procedure after bromodeoxyuridine labeling. Cancer 64:2284–2291.PubMedCrossRefGoogle Scholar
  17. 17.
    Cho KG, Hoshino T, Pitts LH, Nomura K, Shimosato Y. 1988. Proliferative potential of brain métastases. Cancer 62:512–515.PubMedCrossRefGoogle Scholar
  18. 18.
    Brown DC, Gatter KG. 1990. Monoclonal antibody Ki-67: its use in histopathology. Histopathology 17:489–503.PubMedCrossRefGoogle Scholar
  19. 19.
    Matsuno Y, Hirohashi S, Furuya S, Sakamoto M, Mukai K, Shimosato Y. 1990. Heterogeneity of proliferative activity in nodule-in-nodule lesions of small hepatocellular carcinoma. Jpn J Cancer Res 81:1137–1140.PubMedCrossRefGoogle Scholar
  20. 20.
    Asamura H, Nakajima T, Mukai K, Noguchi M, Shimosato Y. 1989. DNA cytofluorometric and nuclear morphometric analyses of lung adenocarcinoma. Cancer 64:1657–1664.Google Scholar
  21. 21.
    Asamura H, Nakajima T, Mukai K, Shimosato Y. 1989. Nuclear DNA content by cyto-fluorometry of stage I adenocarcinoma of the lung in relation to postoperative recurrence. Chest 96:312–318.PubMedCrossRefGoogle Scholar
  22. 22.
    Nomori H, Hirahashi S, Noguchi M, Matsuno Y, Shimosato Y. 1991. Tumor cell heterogeneity and subpopulations with metastatic ability in differentiated adenocarcinoma of the lung. Histologic and cytofluorometric DNA analyses. Chest 99:934–940.PubMedCrossRefGoogle Scholar
  23. 23.
    Nomori H, Nakajima T, Noguchi M, Iga R, Shimosato Y. 1991. Cytofluorometric analysis of métastases from lung adenocarcinoma with special reference to the difference between hematogenous and lymphatic métastases. Cancer 67:2941–2947.PubMedCrossRefGoogle Scholar
  24. 24.
    Kishimoto Y, Murakami Y, Shiraishi M, Hayashi K, Sekiya T. 1992. Aberrations of the p53 tumor suppressor gene in human non-small cell carcinomas of the lung. Cancer Res 52:4799–4804.PubMedGoogle Scholar
  25. 25.
    Shiraishi M, Noguchi M, Shimosato Y, Sekiya T. 1989. Amplification of protooncogenes in surgical specimens of human lung carcinomas. Cancer Res 49:6474–6479.PubMedGoogle Scholar
  26. 26.
    Shiraishi M, Morinaga S, Noguchi M, Shimosato Y, Sekiya T. 1987. Loss of genes on the short arm of chromosome 11 in human lung carcinomas. Jpn J Cancer Res 78:1302–1308.PubMedGoogle Scholar
  27. 27.
    Yokota J, Wada M, Shimosato Y, Terada M, Sugimura T. 1987. Loss of heterozygosity on chromosomes, 3, 13, 17 in small cell carcinoma and on chromosome 3 in adenocarcinoma of the lung. Proc Natl Acad Sci USA 84:9252–9256.PubMedCrossRefGoogle Scholar
  28. 28.
    Kobayashi T, Tsuda H, Noguchi M, Hirohashi S, Shimosato Y, Goya T, Hayata Y. 1990. Association of point mutation in c-Ki-ras oncogene in lung adenocarcinoma with particular reference to cytologic subtypes. Cancer 66:289–294.PubMedCrossRefGoogle Scholar
  29. 29.
    Rosenhuis S, Slebos RJC, Boot AJM, et al. 1988. Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. Cancer Res 48: 5738–5741.Google Scholar
  30. 30.
    Kern JA, Schwartz DA, Nordberg JE, Weiner DB, Greene MI, Torney L, Robinson RA. 1990. p185neu expression in human lung adenocarcinomas predicts shortened survival. Cancer Res 50:5184–5191.PubMedGoogle Scholar
  31. 31.
    Noguchi M, Murakami M, Bennett W, Lupu R, Hui F Jr, Harris CC, Gerwin BI. 1993. Biological consequence of overexpression of a transfected c-erbB-2 gene in immortalized human bronchial epithelial cells. Cancer Res 53:2035–2043.PubMedGoogle Scholar
  32. 32.
    Noguchi M, Maezawa N, Nakanishi Y, Matsuno Y, Shimosato Y, Hirohashi S. 1993. Application of the p53 gene mutation pattern for differential diagnosis of primary versus metastatic lung carcinomas. Diagn Mol Pathol 2:29–35.PubMedGoogle Scholar
  33. 33.
    Rodrigues NR, Rowan A, Smith MEF, et al. 1990. p53 mutations in colorectal cancer. Proc Natl Acad Sci USA 87:7555–7559.PubMedCrossRefGoogle Scholar
  34. 34.
    Hiyoshi H, Matsuno Y, Kato H, Shimosato Y, Hirohashi S. 1992. Clinicopathological significance of nuclear accumulation of tumor suppressor gene p53 product in primary lung cancer. Jpn J Cancer Res 83:101–106.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Masayuki Noguchi
  • Yukío Shimosato

There are no affiliations available

Personalised recommendations